
51 - 200 funcionários
🧬 Biotecnologia
💊 Farmacêutico
🔥 Investimento no último ano
💰 $30.000.000 Post-IPO Secondary - DBV Technologies em 2025-10
Biotechnology • Pharmaceuticals
A DBV Technologies é uma empresa biofarmacêutica global em estágio clínico que desenvolve imunoterapia epicutânea para tratar alergias alimentares e outras doenças mediadas pelo sistema imunológico. Fundada por pediatras, a empresa está avançando sua tecnologia proprietária de adesivo VIASKIN® através de ensaios clínicos — incluindo estudos de Fase 3 para um adesivo para alergia a amendoim (DBV712) e programas em estágios iniciais para alergia ao leite (DBV135) — com o objetivo de reeducar o sistema imunológico usando a exposição controlada da pele a antígenos.
🕒 3 dias atrás
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
🧬 Biotecnologia
💊 Farmacêutico
🔥 Investimento no último ano
💰 $30.000.000 Post-IPO Secondary - DBV Technologies em 2025-10
Biotechnology • Pharmaceuticals
A DBV Technologies é uma empresa biofarmacêutica global em estágio clínico que desenvolve imunoterapia epicutânea para tratar alergias alimentares e outras doenças mediadas pelo sistema imunológico. Fundada por pediatras, a empresa está avançando sua tecnologia proprietária de adesivo VIASKIN® através de ensaios clínicos — incluindo estudos de Fase 3 para um adesivo para alergia a amendoim (DBV712) e programas em estágios iniciais para alergia ao leite (DBV135) — com o objetivo de reeducar o sistema imunológico usando a exposição controlada da pele a antígenos.
• Develop and execute a comprehensive area business plan aligned to national commercial strategy, encompassing territory prioritization, resource allocation, KOL engagement, and quarterly milestone tracking. • Deliver area net sales, market share, and patient start targets by leading, directing, and enabling a team of Regional Business Directors and their Regional Account Managers • Analyze area performance data and field intelligence to identify trends, opportunities, and risks; adjust tactics proactively to maximize commercial impact. • Serve as a senior commercial architect during pre-launch and launch phases; lead area-level market shaping, KOL development, and disease state awareness initiatives. • Identify area-specific market access barriers, competitive dynamics, and adoption challenges; escalate actionable insights to the VP, Sales and commercial operations • Develop deep expertise in peanut allergy epidemiology, EPIT mechanism of action, clinical trial data (EPITOPE, VITESSE), and the competitive landscape to shape strategy and coach the field team. • Partner closely with Medical Science Liaisons (MSLs), Market Access Corporate Account Directors, Marketing, and Patient Services to deliver an integrated, customer-centric approach across the area. • Achieve or exceed quarterly and annual area sales objectives while operating within all compliance and regulatory requirements.
• Bachelor's degree (B.S. or B.A.) from an accredited four-year college or university; life sciences, business, or healthcare-related field preferred. • Minimum 10+ years of pharmaceutical or biopharmaceutical commercial experience; allergy/immunology, rare disease, or pediatric specialty experience preferred • At least 5 years of progressive field sales management • Demonstrated track record of leading multi-layered field organizations through specialty or biologic product launches. • Strong business acumen: ability to interpret area-level sales analytics, develop data-driven business plans, and manage resource allocation. • Deep understanding of specialty pharmacy, biologics access, prior authorization, and hub/patient services models. • Experience building commercial infrastructure in a start-up or early-stage biopharmaceutical environment is preferred. • Proficiency with CRM platforms (Veeva preferred) and standard business tools (Microsoft Office, iPad/tablet-based platforms). • Valid driver's license; ability to travel within area up to 50% of the time, including overnight travel as required.
Candidatar-se🕒 3 dias atrás
Director of Development Operations leading data integrations to strengthen Covenant House’s CRM and empower teams to end youth homelessness.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 3 dias atrás
51 - 200
Executive Director for the National Kidney Foundation driving healthcare initiatives and community impact. Leading fundraising strategies and partnerships to improve kidney health outcomes in Tennessee.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 3 dias atrás
Director, Quality Control overseeing all QC activities for drug development and manufacturing. Ensuring compliance with global regulations and providing technical leadership in pharmaceutical quality control.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $450.000.000 Post-IPO Debt - BioCryst Pharmaceuticals em 2023-04
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 3 dias atrás
Director, Deal Maker at Kyndryl leading and negotiating complex sales deals with state government clients. Driving transformative negotiations and collaborating with internal teams for successful bid submissions.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $161.520 - $290.760 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 3 dias atrás
10.000+ funcionários
Delivery Director for Microsoft platforms managing projects and engagements across multiple workstreams at Guidehouse. Ensuring high-quality execution from initiation through deployment and support.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $226.000 - $376.000 / ano
💰 Grant em 2023-02
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório